Contrasting Health Catalyst (NASDAQ:HCAT) and Evaxion A/S (NASDAQ:EVAX)

Evaxion A/S (NASDAQ:EVAX) and Health Catalyst (NASDAQ:HCAT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Valuation and Earnings

This table compares Evaxion A/S and Health Catalyst”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evaxion A/S	$3.34 million	12.81	-$10.57 million	($0.39)	-13.15
Health Catalyst	$306.58 million	0.56	-$69.50 million	($1.59)	-1.52

Evaxion A/S has higher earnings, but lower revenue than Health Catalyst. Evaxion A/S is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

11.0% of Evaxion A/S shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 41.6% of Evaxion A/S shares are owned by company insiders. Comparatively, 2.6% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings for Evaxion A/S and Health Catalyst, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evaxion A/S	1	0	3	1	2.80
Health Catalyst	1	8	5	0	2.29

Evaxion A/S presently has a consensus target price of $12.33, indicating a potential upside of 140.42%. Health Catalyst has a consensus target price of $4.36, indicating a potential upside of 80.32%. Given Evaxion A/S’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Evaxion A/S is more favorable than Health Catalyst.

Profitability

This table compares Evaxion A/S and Health Catalyst’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Evaxion A/S	N/A	-68.82%	-24.12%
Health Catalyst	-34.05%	-6.67%	-3.21%

Volatility & Risk

Evaxion A/S has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.72, suggesting that its stock price is 72% more volatile than the S&P 500.

Summary

Evaxion A/S beats Health Catalyst on 8 of the 15 factors compared between the two stocks.

About Evaxion A/S

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based vaccine that is in Phase 1/2a trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers. Its programs also include some vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, viral vaccine product candidate for targeting Cytomegalovirus. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.